CAR T-Cell Therapy Research Review, Issue 8
In this issue:
Tumour-restricted delivery of immune-activating molecules by specialised CAR-Ts
Risk factors for severe infections after CAR T-cell therapy in R/R B-ALL
Anti-CD7 allogeneic WU-CART-007 in R/R T-ALL/LBL
Safety profile of CAR-T cell therapy in SLE vs. B-NHL
ZUMA-8: brexucabtagene autoleucel in R/R CLL
T-ICAHT: post-CAR-T thrombocytopenia-based grading & prognostication
CAR transgene levels in tisagenlecleucel-treated R/R B-ALL & DLBCL
Prophylactic tocilizumab before CAR T-cell therapy in older lymphoma patients
Outpatient administration of axicabtagene ciloleucel in R/R DLBCL
Bendamustine vs. fludarabine/ cyclophosphamide lymphodepleting chemotherapy in NHL
Expert contributor
Dr Chanukya Colonne
Chan is a physician-scientist based in Sydney, specialising in CAR-T cell therapy and immuno-oncology, with a focus on advancing treatments for acute myeloid leukaemia (AML). She completed her specialist haematology training at Westmead and Royal Prince Alfred Hospitals, where she gained hands-on experience in the clinical implementation and delivery of CAR-T therapies. Currently, Chan is […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.